Data search
Results for MligTC455_31210
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_31210 | 51 | 1.07 | Mlig455_028581 | Neo: - Age: Down-Up-Down |
KCNH7 | Mlig455_028581 {REF} {Length: 6310} {Pfam: Ion transport protein [PF00520.33, score=119.1]; PAS domain [PF13426.9, score=52.9]; Ion channel [PF07885.18, score=45.3]; Cyclic nucleotide-binding domain [PF00027.31, score=45.2]; PAS fold [PF00989.27, score=31.5]; PAS fold [PF08447.14, score=26.5]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [RH, Score=820, Expect=0.0]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [RH, Score=810, Expect=0.0]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [RH, Score=808, Expect=0.0]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [RH, Score=820, Expect=0.0]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [RH, Score=808, Expect=0.0]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [RH, Score=806, Expect=0.0]} {Dmel: FBgn0003353, sei, seizure, [RH, Score=766, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [RH, Score=746, Expect=0.0]} {Smed: dd_Smed_v6_12621_0_1, dd_Smed_v6_12621_0_1, [Score=793, Expect=0.0]} {RNA1509_40124} {RNA1310_20497} {RNA815_15478} |
Cumulative graph for MligTC455_31210
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | -2.979 | 1.322 | 0.60815 | 1.00000 | |
| RegionR2 | 2.526 | 1.322 | 0.04730 | 0.25782 | |
| RegionR3 | -0.357 | 1.322 | 0.93979 | 1.00000 | |
| RegionR4 | -0.994 | 1.322 | 0.98994 | 1.00000 | |
| RegionR5 | -2.02 | 1.322 | 0.99943 | 1.00000 | |
| RegionR6 | 0.4 | 1.322 | 0.69095 | 1.00000 | |
| RegionR7 | 1.386 | 1.322 | 0.32716 | 0.96163 | |
| RegionR8 | 2.038 | 1.322 | 0.19481 | 0.78981 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | 0.439 | 1.322 | 0.99998 | 1.00000 | |
| RegenerationR2 | -0.612 | 1.322 | 0.40510 | 0.81746 | |
| RegenerationR3 | 1.039 | 1.322 | 0.32689 | 0.75371 | |
| RegenerationR4 | 0.072 | 1.322 | 0.98030 | 1.00000 | |
| RegenerationR5 | 1.659 | 1.322 | 0.11562 | 0.51163 | |
| RegenerationR6 | -3.501 | 1.322 | 0.02896 | 0.21211 | |
| RegenerationBL | -3.897 | 1.322 | 0.13412 | 0.43619 | |
| RegenerationTP | 0.089 | 1.322 | 0.93532 | 1.00000 |
Genes with expression patterns similar to MligTC455_31210
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_31210 | 51 | 1.07 | Mlig455_028581 | Neo: - Age: Down-Up-Down |
KCNH7 | 5 | 1.000 | 1.000 | 1.000 | - | 1.000 | 1.000 | Mlig455_028581 {REF} {Length: 6310} {Pfam: Ion transport protein [PF00520.33, score=119.1]; PAS domain [PF13426.9, score=52.9]; Ion channel [PF07885.18, score=45.3]; Cyclic nucleotide-binding domain [PF00027.31, score=45.2]; PAS fold [PF00989.27, score=31.5]; PAS fold [PF08447.14, score=26.5]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [RH, Score=820, Expect=0.0]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [RH, Score=810, Expect=0.0]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [RH, Score=808, Expect=0.0]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [RH, Score=820, Expect=0.0]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [RH, Score=808, Expect=0.0]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [RH, Score=806, Expect=0.0]} {Dmel: FBgn0003353, sei, seizure, [RH, Score=766, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [RH, Score=746, Expect=0.0]} {Smed: dd_Smed_v6_12621_0_1, dd_Smed_v6_12621_0_1, [Score=793, Expect=0.0]} {RNA1509_40124} {RNA1310_20497} {RNA815_15478} |
| 2. | MligTC455_31212 | 97 | 2.02 | Mlig455_028599, Mlig455_056911 | Neo: - Age: - |
4.96 | 1.000 | 0.998 | 0.995 | - | 0.982 | 0.985 | Mlig455_028599 {REF} {Length: 600} {NoTransDecoderORF} {RNA1310_114554} {RNA815_54362} Mlig455_056911 {REF} {Length: 602} {NoTransDecoderORF} {RNA1310_114554} {RNA815_54362} |
|
| 3. | MligTC455_29510 | 1443 | 30.06 | Mlig455_003367, Mlig455_003369 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.360 Region-enriched R8: 1.897/0.00063 Regeneration-downregulated BL: -2.492 Regeneration-depleted BL: -2.492 |
2.533 | - | 0.968 | 0.776 | - | - | 0.789 | Mlig455_003367 {REF} {Length: 1906} {Pfam: Interferon-induced 6-16 family [PF06140.15, score=25.4]} {RNA1509_46297} {RNA1310_31671} {RNA815_28401} Mlig455_003369 {REF} {Length: 1024} {RNA1509_28087, RNA1509_46297} {RNA1310_31671, RNA1509_28087, RNA1509_46297} {RNA1509_28087, RNA1509_46297, RNA815_17641.1} |
|
| 4. | MligTC455_24162 | 48 | 1 | Mlig455_014024 | Neo: - Age: - |
2.506 | 0.751 | - | 0.800 | - | 0.955 | - | Mlig455_014024 {REF} {Length: 3118} {RNA1310_27501} {RNA815_14263} | |
| 5. | MligTC455_46583 | 1098 | 22.87 | Mlig455_067509 | Neo: - Age: logFC(26M/2M)=-0.318 Region-enriched R8: 2.830/0.00000 Regeneration-depleted TP: -3.677 |
2.45 | - | 0.950 | 0.751 | - | - | 0.749 | Mlig455_067509 {REF} {Length: 1536} {Pfam: Low-density lipoprotein receptor domain class A [PF00057.20, score=25.3]} {Dmel: FBgn0051221, CG31221, [Score=62.8, Expect=5e-12]} {Celegans: WBGene00010290, F58H1.7, [RH, Score=66.6, Expect=1e-13]} {Smed: dd_Smed_v6_2598_0_1, dd_Smed_v6_2598_0_1, [RH, Score=173, Expect=3e-55]} {RNA1509_59060} {RNA1310_28256} {RNA815_15141.1} | |
| 6. | MligTC455_26816 | 355 | 7.39 | Mlig455_062861 | Neo: - Age: logFC(26M/2M)=-0.333 |
TTLL10 | 1.847 | 0.887 | - | - | - | 0.960 | - | Mlig455_062861 {REF} {Length: 4729} {Pfam: Tubulin-tyrosine ligase family [PF03133.17, score=173.8]; YheC/D like ATP-grasp [PF14398.8, score=30.2]; Unstructured region C-term to UIM in Ataxin3 [PF16619.7, score=27.4]; Sugar-transfer associated ATP-grasp [PF14397.8, score=20.6]} {Human: ENSG00000162571, TTLL10, tubulin tyrosine ligase like 10, [RH, Score=323, Expect=5e-100]} {Mouse: ENSMUSG00000029074, Ttll10, tubulin tyrosine ligase-like family, member 10, [RH, Score=319, Expect=2e-98]} {Dmel: FBgn0030823, CG8918, [Score=129, Expect=2e-31]} {Celegans: WBGene00044187, ttll-9, Tubulin Tyrosine Ligase Like, [Score=99.4, Expect=5e-22]} {Smed: dd_Smed_v6_9664_0_1, dd_Smed_v6_9664_0_1, [RH, Score=445, Expect=2e-147]} {RNA1509_23478, RNA1509_31433, RNA1509_39757} {RNA1310_12709.1, RNA1509_23478, RNA1509_31433, RNA1509_39757} {RNA1509_23478, RNA1509_31433, RNA1509_39757, RNA815_2937} |
| 7. | MligTC455_29153 | 62 | 1.28 | Mlig455_018743, Mlig455_018911 | Neo: - Age: - |
1.84 | - | - | 0.888 | - | 0.952 | - | Mlig455_018743 {REF} {Length: 1064} {RNA1509_38365} {RNA1310_117516} {RNA815_19813} Mlig455_018911 {REF} {Length: 2829} {RNA1509_38365} {RNA1310_117516} {RNA815_28950} |
|
| 8. | MligTC455_26817 | 353 | 7.36 | Mlig455_062943 | Neo: - Age: logFC(26M/2M)=-0.515 |
TTLL10 | 1.838 | 0.887 | - | - | - | 0.951 | - | Mlig455_062943 {REF} {Length: 3909} {Pfam: Unstructured region C-term to UIM in Ataxin3 [PF16619.7, score=21.8]} {Human: ENSG00000162571, TTLL10, tubulin tyrosine ligase like 10, [Score=69.7, Expect=2e-12]} {Mouse: ENSMUSG00000029074, Ttll10, tubulin tyrosine ligase-like family, member 10, [Score=58.2, Expect=8e-09]} {Smed: dd_Smed_v6_9664_0_1, dd_Smed_v6_9664_0_1, [Score=87.4, Expect=9e-19]} {RNA1509_23478} {RNA1310_12709.1} {RNA815_2937} |
| 9. | MligTC455_00655 | 14 | 0.29 | Mlig455_065816 | Neo: - Age: - |
1.82 | - | - | 0.852 | - | 0.968 | - | Mlig455_065816 {REF} {Length: 2762} {RNA1310_102038} | |
| 10. | MligTC455_19126 | 10 | 0.2 | Mlig455_009225 | Neo: - Age: - |
1.817 | - | - | 0.863 | - | 0.954 | - | Mlig455_009225 {REF} {Length: 1570} {Pfam: Galactosyltransferase [PF01762.23, score=21.4]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=50.4, Expect=1e-06]} {RNA1310_57689} {RNA815_57743} | |
| 11. | MligTC455_20178 | 15 | 0.31 | Mlig455_053660 | Neo: - Age: - |
1.808 | - | - | 0.850 | - | 0.958 | - | Mlig455_053660 {REF} {Length: 922} {Pfam: LegC3 N-terminal coiled-coil domain [PF18654.3, score=18.5]} {RNA1310_88410} | |
| 12. | MligTC455_53722 | 292 | 6.08 | Mlig455_025654 | Neo: - Age: - |
1.799 | - | 0.979 | - | - | 0.820 | - | Mlig455_025654 {REF} {Length: 1239} {Pfam: Sel1 repeat [PF08238.14, score=31.9]} {Smed: dd_Smed_v6_9387_0_1, dd_Smed_v6_9387_0_1, [RH, Score=194, Expect=2e-62]} {RNA1509_19616} {RNA1310_29567, RNA1509_19616} {RNA1509_19616, RNA815_13742} | |
| 13. | MligTC455_33637 | 187 | 3.9 | Mlig455_027211, Mlig455_027458 | Neo: - Age: - Region-enriched R2: 3.458/0.04514 |
CHRNA10, CHRNA7 | 1.785 | 0.804 | - | - | - | 0.981 | - | Mlig455_027211 {REF} {Length: 782} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=71.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=89.4, Expect=4e-20]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=89.4, Expect=4e-20]; ENSG00000166664, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=89.0, Expect=2e-20]; ENSG00000275917, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=89.0, Expect=1e-20]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=88.6, Expect=7e-20]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=88.6, Expect=7e-20]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=92.0, Expect=4e-21]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=81.6, Expect=9e-18]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=71.6, Expect=2e-14]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=86.3, Expect=1e-19]} {RNA1310_19147.2} {RNA815_8553.2} Mlig455_027458 {REF} {Length: 1493} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=93.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=71.5]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=149, Expect=1e-39]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=148, Expect=1e-39]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=133, Expect=5e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=144, Expect=6e-38]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=144, Expect=7e-38]} {RNA1310_19147.2} {RNA815_8553.2} |
| 14. | MligTC455_24515 | 14 | 0.28 | Mlig455_033346, Mlig455_033365 | Neo: - Age: - |
HTR1B | 1.757 | - | - | 0.785 | - | 0.972 | - | Mlig455_033346 {REF} {Length: 1493} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=216.8]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=27.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=23.5]} {Human: ENSG00000135312, HTR1B, 5-hydroxytryptamine receptor 1B, [Score=211, Expect=4e-63]} {Mouse: ENSMUSG00000021478, Drd1, dopamine receptor D1, [RH, Score=189, Expect=2e-54]} {Dmel: FBgn0004573, 5-HT7, 5-hydroxytryptamine (serotonin) receptor 7, [Score=182, Expect=7e-51]} {Celegans: WBGene00001052, dop-1, DOPamine receptor, [Score=176, Expect=4e-50]} {Smed: dd_Smed_v6_26479_0_1, dd_Smed_v6_26479_0_1, [Score=218, Expect=5e-66]} {RNA1310_132724} Mlig455_033365 {REF} {Length: 1935} {TRANSSPLICED} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=216.2]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=25.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=24.0]} {Human: ENSG00000135312, HTR1B, 5-hydroxytryptamine receptor 1B, [Score=211, Expect=7e-63]} {Mouse: ENSMUSG00000021478, Drd1, dopamine receptor D1, [RH, Score=191, Expect=4e-55]} {Dmel: FBgn0004573, 5-HT7, 5-hydroxytryptamine (serotonin) receptor 7, [Score=182, Expect=7e-51]} {Celegans: WBGene00001052, dop-1, DOPamine receptor, [Score=178, Expect=8e-51]} {Smed: dd_Smed_v6_26479_0_1, dd_Smed_v6_26479_0_1, [Score=216, Expect=2e-65]} {RNA1310_132724} |
| 15. | MligTC455_51200 | 66 | 1.37 | Mlig455_057090 | Neo: - Age: - |
1.739 | 0.789 | - | - | - | 0.950 | - | Mlig455_057090 {REF} {Length: 988} {RNA1310_63663} {RNA815_36272} | |
| 16. | MligTC455_47462 | 529 | 11.01 | Mlig455_012033 | Neo: - Age: Down-Up-Down |
CSMD3 | 1.659 | - | - | 0.705 | - | 0.954 | - | Mlig455_012033 {REF} {Length: 3072} {Pfam: CUB domain [PF00431.22, score=95.8]; Wnt and FGF inhibitory regulator [PF13908.8, score=19.1]} {Human: ENSG00000164796, CSMD3, CUB and Sushi multiple domains 3, [Score=97.1, Expect=5e-20]; ENSG00000183117, CSMD1, CUB and Sushi multiple domains 1, [Score=93.2, Expect=9e-19]} {Mouse: ENSMUSG00000022311, Csmd3, CUB and Sushi multiple domains 3, [Score=95.9, Expect=8e-20]; ENSMUSG00000060924, Csmd1, CUB and Sushi multiple domains 1, [Score=94.7, Expect=2e-19]; ENSMUSG00000028804, Csmd2, CUB and Sushi multiple domains 2, [Score=92.4, Expect=9e-19]} {Dmel: FBgn0003719, tld, tolloid, [Score=58.5, Expect=2e-08]} {Celegans: WBGene00008294, clec-11, C-type LECtin, [Score=52.8, Expect=5e-07]} {Smed: dd_Smed_v6_5652_0_1, dd_Smed_v6_5652_0_1, [Score=77.0, Expect=2e-14]} {RNA1509_35718, RNA1509_6830} {RNA1310_5183.1, RNA1509_35718} {RNA1509_35718, RNA815_5152} |
| 17. | MligTC455_49214 | 6 | 0.13 | Mlig455_068565 | Neo: - Age: - |
0.999 | - | - | - | - | 0.999 | - | Mlig455_068565 {REF} {Length: 1544} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=105.5]} {Smed: dd_Smed_v6_26469_0_1, dd_Smed_v6_26469_0_1, [Score=53.1, Expect=3e-08]} {RNA1310_27155} {RNA815_39321} | |
| 18. | MligTC455_05979 | 11 | 0.23 | Mlig455_067718 | Neo: - Age: - |
0.997 | - | - | - | - | 0.997 | - | Mlig455_067718 {REF} {Length: 1018} {RNA1509_2330} {RNA1310_37520} {RNA815_22367} | |
| 19. | MligTC455_15005 | 13 | 0.26 | Mlig455_007503 | Neo: - Age: - |
0.995 | - | - | - | - | 0.995 | - | Mlig455_007503 {REF} {Length: 2488} {Pfam: Immunoglobulin domain [PF13895.8, score=20.5]} {RNA1310_66411} {RNA815_43821} | |
| 20. | MligTC455_10204 | 14 | 0.29 | Mlig455_049702, Mlig455_049708 | Neo: - Age: - |
0.989 | - | - | - | - | 0.989 | - | Mlig455_049702 {REF} {Length: 217} {NoTransDecoderORF} {RNA1509_48455} {RNA1310_47324} {RNA815_43123} Mlig455_049708 {REF} {Length: 443} {NoTransDecoderORF} {RNA1509_48455} {RNA1310_57782} {RNA815_43123} |
|
| 21. | MligTC455_42103 | 19 | 0.4 | Mlig455_013890 | Neo: - Age: - |
ARID3A | 0.987 | - | - | - | - | 0.987 | - | Mlig455_013890 {REF} {Length: 2772} {Pfam: ARID/BRIGHT DNA binding domain [PF01388.23, score=72.2]} {Human: ENSG00000116017, ARID3A, AT-rich interaction domain 3A, [RH, Score=244, Expect=2e-71]; ENSG00000205143, ARID3C, AT-rich interaction domain 3C, [RH, Score=242, Expect=1e-72]; ENSG00000179361, ARID3B, AT-rich interaction domain 3B, [RH, Score=233, Expect=8e-68]} {Mouse: ENSMUSG00000019564, Arid3a, AT rich interactive domain 3A (BRIGHT-like), [RH, Score=247, Expect=9e-73]; ENSMUSG00000066224, Arid3c, AT rich interactive domain 3C (BRIGHT-like), [RH, Score=245, Expect=2e-74]} {Dmel: FBgn0004795, retn, retained, [RH, Score=241, Expect=2e-68]} {Celegans: WBGene00000476, cfi-1, AT-rich interactive domain-containing protein cfi-1, [RH, Score=231, Expect=3e-68]} {Smed: dd_Smed_v6_13474_0_1, dd_Smed_v6_13474_0_1, [RH, Score=259, Expect=1e-77]} {RNA1509_54880} {RNA1310_44805} {RNA815_49768} |
| 22. | MligTC455_14124 | 9 | 0.19 | Mlig455_004227, Mlig455_031052, Mlig455_031059 | Neo: - |
OTOGL, SSPO | 0.985 | - | - | - | - | 0.985 | - | Mlig455_004227 {REF} {Length: 8347} {Pfam: von Willebrand factor type D domain [PF00094.27, score=218.9]; C8 domain [PF08742.13, score=94.5]; Low-density lipoprotein receptor domain class A [PF00057.20, score=62.7]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=52.1]} {Human: ENSG00000197558, SSPO, SCO-spondin, [Score=506, Expect=2e-143]} {Mouse: ENSMUSG00000029797, Sspo, SCO-spondin, [Score=499, Expect=2e-141]} {Dmel: FBgn0029167, Hml, Hemolectin, [Score=327, Expect=5e-89]} {Celegans: WBGene00020481, T13C2.6, [Score=107, Expect=5e-23]} {Smed: dd_Smed_v6_9342_0_1, dd_Smed_v6_9342_0_1, [Score=1126, Expect=0.0]} {RNA1509_11979, RNA1509_44751} {RNA1310_598, RNA1509_44751} {RNA1509_44751, RNA815_582} Mlig455_031052 {REF} {Length: 3393} {Pfam: von Willebrand factor type D domain [PF00094.27, score=117.0]; C8 domain [PF08742.13, score=60.4]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=40.8]} {Human: ENSG00000165899, OTOGL, otogelin like, [Score=200, Expect=1e-51]} {Mouse: ENSMUSG00000001930, Vwf, Von Willebrand factor, [Score=200, Expect=8e-52]; ENSMUSG00000091455, Otogl, otogelin-like, [Score=196, Expect=1e-50]} {Dmel: FBgn0029167, Hml, Hemolectin, [Score=149, Expect=4e-36]} {Smed: dd_Smed_v6_9342_0_1, dd_Smed_v6_9342_0_1, [Score=497, Expect=7e-154]} {RNA1509_47011} {RNA1310_598} {RNA815_582} Mlig455_031059 {REF} {Length: 5292} {Pfam: von Willebrand factor type D domain [PF00094.27, score=221.4]; C8 domain [PF08742.13, score=99.8]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=55.1]; Low-density lipoprotein receptor domain class A [PF00057.20, score=52.2]} {Human: ENSG00000197558, SSPO, SCO-spondin, [Score=489, Expect=4e-142]} {Mouse: ENSMUSG00000029797, Sspo, SCO-spondin, [Score=488, Expect=6e-142]} {Dmel: FBgn0029167, Hml, Hemolectin, [Score=322, Expect=1e-88]} {Celegans: WBGene00003071, lrp-1, Low-density lipoprotein receptor-related protein, [Score=74.7, Expect=6e-13]} {Smed: dd_Smed_v6_9342_0_1, dd_Smed_v6_9342_0_1, [Score=1061, Expect=0.0]} {RNA1509_47011} {RNA1310_598} {RNA815_582} |
| 23. | MligTC455_22853 | 33 | 0.7 | Mlig455_019405, Mlig455_059068 | Neo: - Age: - |
0.98 | - | - | - | - | 0.980 | - | Mlig455_019405 {REF} {Length: 4200} {Smed: dd_Smed_v6_3718_0_2, dd_Smed_v6_3718_0_2, [Score=66.2, Expect=9e-12]} {RNA1310_63811} Mlig455_059068 {REF} {Length: 4200} {Pfam: Integrase zinc binding domain [PF17921.3, score=58.4]; Integrase core domain [PF00665.28, score=32.8]} {Smed: dd_Smed_v6_6563_0_1, dd_Smed_v6_6563_0_1, [Score=63.5, Expect=1e-10]} {RNA1310_63811} |
|
| 24. | MligTC455_15324 | 212 | 4.42 | Mlig455_018628 | Neo: - Age: - |
CAPN7 | 0.978 | - | - | 0.978 | - | - | - | Mlig455_018628 {REF} {Length: 2837} {TRANSSPLICED} {Pfam: Calpain family cysteine protease [PF00648.23, score=151.6]; Calpain large subunit, domain III [PF01067.24, score=65.5]; MIT (microtubule interacting and transport) domain [PF04212.20, score=58.0]} {Human: ENSG00000131375, CAPN7, calpain 7, [RH, Score=818, Expect=0.0]} {Mouse: ENSMUSG00000021893, Capn7, calpain 7, [RH, Score=830, Expect=0.0]} {Dmel: FBgn0003464, sol, small optic lobes, [Score=121, Expect=1e-27]} {Celegans: WBGene00000543, clp-2, CaLPain family, [RH, Score=621, Expect=0.0]} {Smed: dd_Smed_v6_6402_0_1, dd_Smed_v6_6402_0_1, [RH, Score=812, Expect=0.0]} {RNA1509_9441} {RNA1310_7284} {RNA815_5790} |
| 25. | MligTC455_35325 | 26 | 0.54 | Mlig455_008452, Mlig455_031353, Mlig455_056519 | Neo: - Age: - |
HTR3A | 0.978 | - | - | - | - | 0.978 | - | Mlig455_008452 {REF} {Length: 1552} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=81.9]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=26.8]} {Human: ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=97.4, Expect=2e-22]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=92.8, Expect=1e-20]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=92.8, Expect=6e-21]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=91.7, Expect=2e-20]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=90.9, Expect=3e-20]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=93.2, Expect=4e-21]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=98.2, Expect=6e-23]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=88.6, Expect=9e-20]} {RNA1509_7752} {RNA1310_93708} {RNA815_49010} Mlig455_031353 {REF} {Length: 1802} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=61.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=54.4]} {Human: ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=103, Expect=5e-25]; ENSG00000149305, HTR3B, 5-hydroxytryptamine receptor 3B, [Score=101, Expect=1e-24]} {Mouse: ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=100, Expect=4e-24]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=98.2, Expect=2e-23]; ENSMUSG00000008590, Htr3b, 5-hydroxytryptamine (serotonin) receptor 3B, [Score=96.3, Expect=7e-23]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=93.6, Expect=6e-22]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=100, Expect=1e-24]} {Smed: dd_Smed_v6_11955_0_1, dd_Smed_v6_11955_0_1, [Score=90.5, Expect=5e-21]} {RNA1509_7752} {RNA1310_93708} {RNA815_49010} Mlig455_056519 {REF} {Length: 1867} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=81.9]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=26.8]} {Human: ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=97.4, Expect=2e-22]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=92.8, Expect=1e-20]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=92.8, Expect=6e-21]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=91.7, Expect=2e-20]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=90.9, Expect=3e-20]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=93.2, Expect=4e-21]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=98.2, Expect=6e-23]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=88.6, Expect=9e-20]} {RNA1509_53098} {RNA1310_93708} {RNA815_49010} |
| 26. | MligTC455_50029 | 35 | 0.74 | Mlig455_010619, Mlig455_010708 | Neo: - Age: - |
FOXA1 | 0.978 | - | - | - | - | 0.978 | - | Mlig455_010619 {REF} {Length: 1170} {Pfam: Forkhead domain [PF00250.20, score=110.8]} {Human: ENSG00000129514, FOXA1, forkhead box A1, [Score=168, Expect=3e-48]; ENSG00000170608, FOXA3, forkhead box A3, [Score=164, Expect=1e-47]; ENSG00000125798, FOXA2, forkhead box A2, [Score=163, Expect=2e-46]} {Mouse: ENSMUSG00000035451, Foxa1, forkhead box A1, [Score=167, Expect=3e-48]; ENSMUSG00000040891, Foxa3, forkhead box A3, [Score=164, Expect=7e-48]; ENSMUSG00000037025, Foxa2, forkhead box A2, [Score=164, Expect=7e-47]} {Dmel: FBgn0000659, fkh, fork head, [Score=169, Expect=2e-48]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [Score=150, Expect=3e-42]} {Smed: dd_Smed_v6_10718_0_4, dd_Smed_v6_10718_0_4, [Score=175, Expect=2e-51]} Mlig455_010708 {REF} {Length: 1194} {Pfam: Forkhead domain [PF00250.20, score=110.9]} {Human: ENSG00000129514, FOXA1, forkhead box A1, [Score=168, Expect=3e-48]; ENSG00000125798, FOXA2, forkhead box A2, [Score=163, Expect=2e-46]; ENSG00000170608, FOXA3, forkhead box A3, [Score=163, Expect=1e-47]} {Mouse: ENSMUSG00000035451, Foxa1, forkhead box A1, [Score=167, Expect=4e-48]; ENSMUSG00000040891, Foxa3, forkhead box A3, [Score=165, Expect=2e-48]; ENSMUSG00000037025, Foxa2, forkhead box A2, [Score=164, Expect=9e-47]} {Dmel: FBgn0000659, fkh, fork head, [Score=168, Expect=2e-48]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [Score=151, Expect=2e-42]} {Smed: dd_Smed_v6_10718_0_3, dd_Smed_v6_10718_0_3, [Score=175, Expect=2e-51]} |
| 27. | MligTC455_24787 | 87 | 1.82 | Mlig455_065253 | Neo: - Age: - |
0.974 | - | - | - | - | 0.974 | - | Mlig455_065253 {REF} {Length: 1051} {TRANSSPLICED} {RNA1509_24218} {RNA1310_25312.2} {RNA815_14520} | |
| 28. | MligTC455_46582 | 6815 | 141.97 | Mlig455_027253, Mlig455_027264 | Neo: - Age: - Region-enriched R8: 2.137/0.00000 Regeneration-downregulated TP: -1.999 Regeneration-depleted TP: -1.999 |
0.974 | - | 0.974 | - | - | - | - | Mlig455_027253 {REF} {Length: 2256} {Pfam: Low-density lipoprotein receptor domain class A [PF00057.20, score=25.3]} {Dmel: FBgn0051221, CG31221, [Score=63.2, Expect=5e-12]} {Celegans: WBGene00010290, F58H1.7, [RH, Score=66.6, Expect=1e-13]} {Smed: dd_Smed_v6_2598_0_1, dd_Smed_v6_2598_0_1, [RH, Score=173, Expect=3e-55]} {RNA1509_59060} {RNA1310_28256} {RNA815_15141.1} Mlig455_027264 {REF} {Length: 973} {Dmel: FBgn0051221, CG31221, [Score=53.5, Expect=1e-08]} {Celegans: WBGene00010290, F58H1.7, [Score=50.4, Expect=7e-08]} {Smed: dd_Smed_v6_2598_0_1, dd_Smed_v6_2598_0_1, [Score=147, Expect=5e-45]} {RNA1509_59060} {RNA1310_28256} {RNA815_15141.1} |
|
| 29. | MligTC455_14578 | 33 | 0.69 | Mlig455_033066 | Neo: - Age: - |
0.973 | - | - | - | - | 0.973 | - | Mlig455_033066 {REF} {Length: 2292} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=137.2]} {Smed: dd_Smed_v6_19599_0_1, dd_Smed_v6_19599_0_1, [Score=63.9, Expect=1e-10]} {RNA1310_28762} {RNA815_42177} | |
| 30. | MligTC455_23922 | 8 | 0.17 | Mlig455_001765 | Neo: - Age: Down-Up-Down |
0.971 | - | - | - | - | 0.971 | - | Mlig455_001765 {REF} {Length: 4721} {Pfam: AMP-binding enzyme [PF00501.30, score=68.9]} {RNA1509_37800} {RNA1310_40483} {RNA815_30709} | |
| 31. | MligTC455_11494 | 99 | 2.06 | Mlig455_055605 | Neo: - Age: Down-Up-Down |
HS3ST5 | 0.968 | - | - | - | - | 0.968 | - | Mlig455_055605 {REF} {Length: 2196} {Pfam: Sulfotransferase domain [PF00685.29, score=91.7]; Sulfotransferase family [PF13469.8, score=45.8]} {Human: ENSG00000249853, HS3ST5, heparan sulfate-glucosamine 3-sulfotransferase 5, [RH, Score=256, Expect=1e-82]} {Mouse: ENSMUSG00000044499, Hs3st5, heparan sulfate (glucosamine) 3-O-sulfotransferase 5, [RH, Score=257, Expect=2e-83]} {Dmel: FBgn0031005, Hs3st-B, Heparan sulfate 3-O sulfotransferase-B, [Score=205, Expect=9e-63]} {Celegans: WBGene00044303, hst-3.2, Heparan SulphoTransferase, [Score=215, Expect=7e-68]} {Smed: dd_Smed_v6_81402_0_1, dd_Smed_v6_81402_0_1, [Score=123, Expect=7e-34]} {RNA1310_37118} {RNA815_58609} |
| 32. | MligTC455_19888 | 22 | 0.46 | Mlig455_066525 | Neo: - Age: - |
AC254952.1 | 0.967 | - | - | - | - | 0.967 | - | Mlig455_066525 {REF} {Length: 1890} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=188.2]; Unstructured region C-term to UIM in Ataxin3 [PF16619.7, score=20.4]} {Human: ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=188, Expect=3e-55]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=188, Expect=3e-55]; ENSG00000166664, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=188, Expect=5e-57]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=188, Expect=3e-55]; ENSG00000275917, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=185, Expect=4e-56]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=195, Expect=4e-58]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=242, Expect=1e-75]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=175, Expect=7e-51]} {Smed: dd_Smed_v6_12182_0_1, dd_Smed_v6_12182_0_1, [Score=228, Expect=9e-71]} {RNA1310_34222.1} {RNA815_33884} |
| 33. | MligTC455_53285 | 6 | 0.13 | Mlig455_061305 | Neo: - Age: - |
0.967 | - | - | - | - | 0.967 | - | Mlig455_061305 {REF} {Length: 422} {NoTransDecoderORF} | |
| 34. | MligTC455_26562 | 51 | 1.05 | Mlig455_003821 | Neo: - Age: - Region-enriched R4: 4.788/0.04787 |
0.964 | - | - | - | - | 0.964 | - | Mlig455_003821 {REF} {Length: 3329} {NoTransDecoderORF} {RNA1509_310} {RNA1310_3669} {RNA815_20255} | |
| 35. | MligTC455_27521 | 681 | 14.19 | Mlig455_050046 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=0.667 Region-enriched R2: 1.375/0.04610 |
ABCG2 | 0.963 | - | - | - | - | 0.963 | - | Mlig455_050046 {REF} {Length: 3109} {Pfam: ABC-2 type transporter [PF01061.26, score=96.6]; ABC transporter [PF00005.29, score=96.0]; ABC-2 type transporter [PF19055.2, score=48.9]; AAA domain, putative AbiEii toxin, Type IV TA system [PF13304.8, score=25.0]} {Human: ENSG00000118777, ABCG2, ATP binding cassette subfamily G member 2 (Junior blood group), [Score=248, Expect=2e-72]} {Mouse: ENSMUSG00000029802, Abcg2, ATP binding cassette subfamily G member 2 (Junior blood group), [Score=249, Expect=4e-73]} {Dmel: FBgn0020445, E23, Early gene at 23, [RH, Score=389, Expect=3e-122]} {Celegans: WBGene00015479, wht-1, ABC transporter ATP-binding protein/permease wht-1, [Score=220, Expect=4e-63]} {Smed: dd_Smed_v6_4081_0_1, dd_Smed_v6_4081_0_1, [RH, Score=222, Expect=4e-63]} {RNA1509_19841, RNA1509_37967, RNA1509_52359} {RNA1310_6299.1, RNA1509_37967, RNA1509_52359} {RNA1509_37967, RNA1509_52359, RNA815_1994.1} |
| 36. | MligTC455_25410 | 47 | 0.97 | Mlig455_026185 | Neo: - Age: Up-Down-Down Region-enriched R2: 8.036/0.00469 |
0.961 | - | - | - | - | 0.961 | - | Mlig455_026185 {REF} {Length: 3002} {Pfam: Variant SH3 domain [PF07653.19, score=19.6]; Growth-arrest specific micro-tubule binding [PF13851.8, score=19.3]} {Mouse: ENSMUSG00000034156, Tspoap1, TSPO associated protein 1, [Score=54.7, Expect=6e-07]} {Smed: dd_Smed_v6_14584_0_1, dd_Smed_v6_14584_0_1, [Score=140, Expect=7e-35]} {RNA1509_45271} {RNA1310_5741} {RNA815_46868} | |
| 37. | MligTC455_27522 | 684 | 14.26 | Mlig455_050093 | Neo: - Age: logFC(26M/2M)=5.091 |
0.96 | - | - | - | - | 0.960 | - | Mlig455_050093 {REF} {Length: 1057} {NoTransDecoderORF} {RNA1509_37967} {RNA1310_6299.1} {RNA815_1994.1} | |
| 38. | MligTC455_01796 | 16 | 0.32 | Mlig455_044192 | Neo: - Age: - |
0.959 | - | - | - | - | 0.959 | - | Mlig455_044192 {REF} {Length: 437} {NoTransDecoderORF} {RNA1509_18603} {RNA1310_53435} {RNA815_26807} | |
| 39. | MligTC455_02461 | 5 | 0.11 | Mlig455_019900 | Neo: - Age: - |
0.959 | - | - | - | - | 0.959 | - | Mlig455_019900 {REF} {Length: 253} {NoTransDecoderORF} {RNA1509_34377} {RNA1310_100135} | |
| 40. | MligTC455_24786 | 300 | 6.25 | Mlig455_032143, Mlig455_049302 | Neo: - Age: logFC(26M/2M)=-0.528 |
0.958 | - | - | - | - | 0.958 | - | Mlig455_032143 {REF} {Length: 358} {NoTransDecoderORF} {RNA1509_36687} {RNA1310_1894} {RNA815_5614.1} Mlig455_049302 {REF} {Length: 3378} {Pfam: PT repeat [PF04886.14, score=51.8]} {RNA1509_45844} {RNA1310_12902.2} {RNA815_515.1} |
|
| 41. | MligTC455_06577 | 7 | 0.14 | Mlig455_044334 | Neo: - Age: Up-Down-Down |
0.957 | - | - | - | - | 0.957 | - | Mlig455_044334 {REF} {Length: 706} | |
| 42. | MligTC455_40204 | 348 | 7.24 | Mlig455_064913, Mlig455_066843 | Neo: - Age: logFC(26M/2M)=-0.350 |
0.957 | - | - | - | - | 0.957 | - | Mlig455_064913 {REF} {Length: 1143} {NoTransDecoderORF} {RNA1509_52747} {RNA1310_89294} {RNA815_41786} Mlig455_066843 {REF} {Length: 633} {NoTransDecoderORF} {RNA1310_106751} {RNA815_41786} |
|
| 43. | MligTC455_33875 | 32 | 0.67 | Mlig455_039631 | Neo: - Age: - |
0.956 | - | - | - | - | 0.956 | - | Mlig455_039631 {REF} {Length: 3055} {TRANSSPLICED} {RNA1509_14655, RNA1509_53977} {RNA1310_22046.1, RNA1509_53977} {RNA1509_53977, RNA815_8738} | |
| 44. | MligTC455_09686 | 4 | 0.08 | Mlig455_061629 | Neo: - Age: - |
0.955 | - | - | - | - | 0.955 | - | Mlig455_061629 {REF} {Length: 1698} {NoTransDecoderORF} {RNA1509_20320} {RNA1310_104302} {RNA815_52785.1} | |
| 45. | MligTC455_15053 | 12 | 0.26 | Mlig455_016326 | Neo: - Age: - |
0.955 | - | - | - | - | 0.955 | - | Mlig455_016326 {REF} {Length: 2006} {NoTransDecoderORF} {RNA1509_50409, RNA1509_54815} {RNA1310_146928, RNA1509_50409} {RNA1509_50409, RNA815_32053} | |
| 46. | MligTC455_21405 | 54 | 1.13 | Mlig455_047017, Mlig455_052380 | Neo: - Age: - Region-enriched R4: 5.038/0.00957 |
0.955 | - | - | - | - | - | 0.955 | Mlig455_047017 {REF} {Length: 2240} {RNA1310_30090} {RNA815_47725} Mlig455_052380 {REF} {Length: 1329} {RNA1509_49721} {RNA1310_33296} {RNA815_49583} |
|
| 47. | MligTC455_40989 | 801 | 16.68 | Mlig455_016294 | Neo: - Age: logFC(26M/2M)=0.270 |
PKD2 | 0.955 | - | - | - | - | 0.955 | - | Mlig455_016294 {REF} {Length: 3179} {Pfam: Polycystin cation channel [PF08016.14, score=486.5]; Ion transport protein [PF00520.33, score=90.3]; EF hand [PF00036.34, score=23.7]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=718, Expect=0.0]; ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [RH, Score=712, Expect=0.0]} {Mouse: ENSMUSG00000037578, Pkd2l1, polycystic kidney disease 2-like 1, [RH, Score=704, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=310, Expect=2e-91]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=370, Expect=7e-116]} {Smed: dd_Smed_v6_13327_0_1, dd_Smed_v6_13327_0_1, [RH, Score=743, Expect=0.0]} {RNA1509_14023, RNA1509_24240} {RNA1310_4836.1, RNA1509_14023, RNA1509_24240} {RNA1509_14023, RNA1509_24240, RNA815_4677} |
| 48. | MligTC455_54226 | 52 | 1.09 | Mlig455_037435, Mlig455_037458 | Neo: - Age: - |
NETO2 | 0.955 | - | - | - | - | 0.955 | - | Mlig455_037435 {REF} {Length: 2663} {Pfam: CUB domain [PF00431.22, score=52.2]; Low-density lipoprotein receptor domain class A [PF00057.20, score=31.7]} {Human: ENSG00000171208, NETO2, neuropilin and tolloid like 2, [Score=96.3, Expect=3e-20]} {Mouse: ENSMUSG00000036902, Neto2, neuropilin (NRP) and tolloid (TLL)-like 2, [Score=97.8, Expect=6e-21]} {Dmel: FBgn0265416, Neto, Neuropilin and tolloid-like, [Score=87.8, Expect=1e-17]} {Celegans: WBGene00019360, neto-1, NETO (NEuropilin and TOlloid-like) homolog, [Score=77.4, Expect=4e-15]} {Smed: dd_Smed_v6_8579_0_1, dd_Smed_v6_8579_0_1, [Score=87.0, Expect=1e-17]} {RNA1310_38111} Mlig455_037458 {REF} {Length: 2349} {Pfam: CUB domain [PF00431.22, score=52.1]; Low-density lipoprotein receptor domain class A [PF00057.20, score=31.7]} {Human: ENSG00000171208, NETO2, neuropilin and tolloid like 2, [RH, Score=144, Expect=9e-37]} {Mouse: ENSMUSG00000036902, Neto2, neuropilin (NRP) and tolloid (TLL)-like 2, [RH, Score=146, Expect=1e-37]} {Dmel: FBgn0265416, Neto, Neuropilin and tolloid-like, [Score=117, Expect=2e-27]} {Celegans: WBGene00019360, neto-1, NETO (NEuropilin and TOlloid-like) homolog, [Score=105, Expect=1e-24]} {Smed: dd_Smed_v6_8579_0_1, dd_Smed_v6_8579_0_1, [Score=115, Expect=6e-27]} {RNA1310_38111} |
| 49. | MligTC455_10605 | 2 | 0.04 | Mlig455_047968 | Neo: - Age: - |
0.954 | - | - | - | - | 0.954 | - | Mlig455_047968 {REF} {Length: 297} {NoTransDecoderORF} {RNA1509_34377} {RNA1310_100135} {RNA815_25886} | |
| 50. | MligTC455_47574 | 716 | 14.92 | Mlig455_028318, Mlig455_066192 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=1.060 Region-enriched R2: 1.667/0.01738 |
MAN1C1 | 0.954 | - | - | - | - | 0.954 | - | Mlig455_028318 {REF} {Length: 2839} {TRANSSPLICED} {Pfam: Glycosyl hydrolase family 47 [PF01532.22, score=378.3]; Glycosyl hydrolase family 76 [PF03663.16, score=19.1]} {Human: ENSG00000117643, MAN1C1, mannosidase alpha class 1C member 1, [Score=269, Expect=4e-82]; ENSG00000198162, MAN1A2, mannosidase alpha class 1A member 2, [Score=268, Expect=1e-81]} {Mouse: ENSMUSG00000008763, Man1a2, mannosidase, alpha, class 1A, member 2, [Score=268, Expect=1e-81]; ENSMUSG00000037306, Man1c1, mannosidase, alpha, class 1C, member 1, [Score=267, Expect=1e-81]; ENSMUSG00000003746, Man1a, mannosidase 1, alpha, [Score=263, Expect=2e-79]} {Dmel: FBgn0259170, alpha-Man-Ia, alpha-Mannosidase class I a, [Score=266, Expect=5e-81]} {Celegans: WBGene00008258, mans-2, Mannosyl-oligosaccharide 1,2-alpha-mannosidase C52E4.5, [Score=249, Expect=2e-75]} {Smed: dd_Smed_v6_6801_0_1, dd_Smed_v6_6801_0_1, [Score=265, Expect=2e-81]} {RNA1509_9530} {RNA1310_9474.1} {RNA815_6962} Mlig455_066192 {REF} {Length: 2836} {TRANSSPLICED} {Pfam: Glycosyl hydrolase family 47 [PF01532.22, score=378.3]; Glycosyl hydrolase family 76 [PF03663.16, score=19.1]} {Human: ENSG00000117643, MAN1C1, mannosidase alpha class 1C member 1, [Score=269, Expect=4e-82]; ENSG00000198162, MAN1A2, mannosidase alpha class 1A member 2, [Score=268, Expect=1e-81]} {Mouse: ENSMUSG00000008763, Man1a2, mannosidase, alpha, class 1A, member 2, [Score=268, Expect=1e-81]; ENSMUSG00000037306, Man1c1, mannosidase, alpha, class 1C, member 1, [Score=267, Expect=1e-81]; ENSMUSG00000003746, Man1a, mannosidase 1, alpha, [Score=263, Expect=2e-79]} {Dmel: FBgn0259170, alpha-Man-Ia, alpha-Mannosidase class I a, [Score=266, Expect=5e-81]} {Celegans: WBGene00008258, mans-2, Mannosyl-oligosaccharide 1,2-alpha-mannosidase C52E4.5, [Score=249, Expect=2e-75]} {Smed: dd_Smed_v6_6801_0_1, dd_Smed_v6_6801_0_1, [Score=265, Expect=2e-81]} {RNA1509_53617, RNA1509_9530} {RNA1310_9474.1, RNA1509_53617} {RNA1509_53617, RNA815_6962} |
| 51. | MligTC455_55494 | 2 | 0.05 | Mlig455_004790 | Neo: - Age: - |
0.954 | - | - | - | - | 0.954 | - | Mlig455_004790 {REF} {Length: 600} {Pfam: Receptor family ligand binding region [PF01094.30, score=64.3]; Periplasmic binding protein [PF13458.8, score=19.1]} | |
| 52. | MligTC455_00622 | 2 | 0.05 | Mlig455_047108 | Neo: - Age: - |
0.952 | - | - | - | - | 0.952 | - | Mlig455_047108 {REF} {Length: 64} {NoTransDecoderORF} | |
| 53. | MligTC455_12203 | 8 | 0.17 | Mlig455_061049 | Neo: - Age: - |
0.952 | - | - | - | - | 0.952 | - | Mlig455_061049 {REF} {Length: 1492} {RNA1509_16662} {RNA1310_122445} {RNA815_4833.1} | |
| 54. | MligTC455_40947 | 334 | 6.97 | Mlig455_035957 | Neo: - Age: Up-Down-Down |
FSIP1 | 0.952 | - | - | - | - | 0.952 | - | Mlig455_035957 {REF} {Length: 3167} {TRANSSPLICED} {Pfam: FSIP1 family [PF15554.8, score=178.4]} {Human: ENSG00000150667, FSIP1, fibrous sheath interacting protein 1, [RH, Score=108, Expect=5e-24]} {Mouse: ENSMUSG00000027344, Fsip1, fibrous sheath-interacting protein 1, [RH, Score=101, Expect=4e-22]} {Smed: dd_Smed_v6_16017_0_1, dd_Smed_v6_16017_0_1, [RH, Score=119, Expect=2e-28]} {RNA1509_20339} {RNA1310_6204.1} {RNA815_13781} |
| 55. | MligTC455_49697 | 47 | 0.97 | Mlig455_004472 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.634 Region-enriched R2: 5.369/0.00560 |
SVOP | 0.952 | - | - | 0.952 | - | - | - | Mlig455_004472 {REF} {Length: 3727} {Pfam: Major Facilitator Superfamily [PF07690.18, score=79.8]; Sugar (and other) transporter [PF00083.26, score=79.5]} {Human: ENSG00000166111, SVOP, SV2 related protein, [Score=223, Expect=8e-66]} {Mouse: ENSMUSG00000042078, Svop, SV2 related protein, [Score=206, Expect=1e-59]} {Dmel: FBgn0034956, CG4324, [Score=164, Expect=8e-45]} {Celegans: WBGene00014021, svop-1, Putative transporter svop-1, [Score=193, Expect=2e-55]} {Smed: dd_Smed_v6_3645_0_1, dd_Smed_v6_3645_0_1, [Score=179, Expect=1e-50]} {RNA1509_47809} {RNA1310_13019, RNA1509_47809} {RNA1509_47809, RNA815_31681} |
| 56. | MligTC455_49875 | 59 | 1.22 | Mlig455_027217 | Neo: - Age: - |
0.952 | - | - | - | - | 0.952 | - | Mlig455_027217 {REF} {Length: 1809} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=88.9]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=64.7, Expect=5e-12]} {Celegans: WBGene00008997, lgc-31, Ligand-Gated ion Channel, [Score=70.9, Expect=3e-14]} {Smed: dd_Smed_v6_12146_0_1, dd_Smed_v6_12146_0_1, [Score=67.0, Expect=6e-13]} {RNA1310_26175} {RNA815_7952} | |
| 57. | MligTC455_30594 | 23 | 0.48 | Mlig455_038529, Mlig455_052221 | Neo: - Age: - |
0.951 | - | - | - | - | 0.951 | - | Mlig455_038529 {REF} {Length: 805} {Pfam: Lecithin retinol acyltransferase [PF04970.15, score=35.1]} {RNA1509_40834} {RNA1310_11051} {RNA815_3523.1} Mlig455_052221 {REF} {Length: 7356} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=40.2]; Mab-21 protein [PF03281.16, score=18.9]} {RNA1509_14346, RNA1509_40834} {RNA1310_11051, RNA1509_14346} {RNA1509_14346, RNA815_3523.1} |
|
| 58. | MligTC455_31082 | 93 | 1.93 | Mlig455_020193 | Neo: - Age: Up-Down-Up |
0.951 | - | - | - | - | 0.951 | - | Mlig455_020193 {REF} {Length: 1952} {RNA1509_54750} {RNA1310_22843} {RNA815_11564.1} | |
| 59. | MligTC455_42489 | 236 | 4.91 | Mlig455_046431 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.696 Region-enriched R2: 2.739/0.01786 |
0.951 | - | - | - | - | 0.951 | - | Mlig455_046431 {REF} {Length: 2159} {Smed: dd_Smed_v6_12856_0_1, dd_Smed_v6_12856_0_1, [RH, Score=107, Expect=3e-27]} {RNA1509_6433} {RNA1310_24046, RNA1509_6433} {RNA1509_6433, RNA815_8453} | |
| 60. | MligTC455_49355 | 2700 | 56.26 | Mlig455_011203, Mlig455_011231, Mlig455_024733 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.392 Region-enriched R8: 3.090/0.00006 |
0.951 | - | 0.951 | - | - | - | - | Mlig455_011203 {REF} {Length: 619} {RNA1509_40338} {RNA1310_65068} {RNA815_33500.1} Mlig455_011231 {REF} {Length: 1438} {RNA1509_40338} {RNA1310_65068, RNA1509_40338} {RNA1509_40338, RNA815_33500.1} Mlig455_024733 {REF} {Length: 1436} {RNA1509_40338} {RNA1310_65068} {RNA815_33500.1} |
|
| 61. | MligTC455_11139 | 13 | 0.26 | Mlig455_023498 | Neo: - Age: - |
0.95 | - | - | - | - | 0.950 | - | Mlig455_023498 {REF} {Length: 478} {NoTransDecoderORF} {RNA1509_18763} {RNA1310_2578.1} {RNA815_40003} |